Page last updated: 2024-08-21

pyrazines and carnitine

pyrazines has been researched along with carnitine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dou, QP; Guan, L; Guo, H; Huang, H; Li, B; Li, X; Liao, S; Liu, C; Liu, J; Liu, N; Liu, S; Song, W; Tang, P; Xu, L; Yang, C; Zhang, C; Zhao, K1
Gong, X; He, X; Sun, M; Sun, Y; Wang, BO; Wang, M; Wang, X; Wang, Z; Wei, X; Yi, F; Zhang, Y; Zhou, Z1

Other Studies

2 other study(ies) available for pyrazines and carnitine

ArticleYear
HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo.
    PloS one, 2012, Volume: 7, Issue:12

    Topics: Acetylation; Animals; Antineoplastic Agents; bcl-2-Associated X Protein; Boronic Acids; Bortezomib; Carnitine; Caspases; Cell Death; Cell Proliferation; Chromatin; Cyclin-Dependent Kinase Inhibitor p21; Drug Synergism; Endoplasmic Reticulum Stress; Enzyme Activation; Hep G2 Cells; Histone Deacetylase Inhibitors; Histones; Humans; Male; Mice; Models, Biological; Poly(ADP-ribose) Polymerases; Proteasome Inhibitors; Pyrazines; RNA, Small Interfering; Unfolded Protein Response; Xenograft Model Antitumor Assays

2012
Therapeutic Potential of Novel Twin Compounds Containing Tetramethylpyrazine and Carnitine Substructures in Experimental Ischemic Stroke.
    Oxidative medicine and cellular longevity, 2017, Volume: 2017

    Topics: Animals; Brain Ischemia; Carnitine; Disease Models, Animal; Male; NADPH Oxidase 2; Neuroprotective Agents; Pyrazines; Rats; Rats, Sprague-Dawley; Stroke

2017